Please login to the form below
Cell and gene therapy manufacturing
This page shows the latest Cell and gene therapy manufacturing news and features for those working in and with pharma, biotech and healthcare.
Merck KGaA announces launch of start-up collaboration programme in Asia
The programme will support companies across Asia working on relevant topics within healthcare, life sciences, electronics and smart manufacturing, to devise proofs-of-concepts, run pilot projects and develop partnerships with ... Merck. The company noted
Latest news
-
Amicus forms gene therapy manufacturing partnership with Catalent
Biotech invests to speed gene therapies into clinical trials. US biotech Amicus Therapeutics is to work with drug development services company Catalent Biologics to develop its cell and gene therapy manufacturing ... capabilities. Thermo Fisher will
-
Oxford Biomedica gets £53m cash injection from Novo venture arm
Cell and gene therapy specialist Oxford Biomedica has been given a £53.5m infusion of cash from Novo Holdings in exchange for a 10% stake in the company. ... The company is far from alone in the cell and gene therapy manufacturing and R&D field, with
-
Oxford Biomedica taps Microsoft to progress gene therapy delivery tech
These new technologies will help advance the next generation of cell and gene delivery approaches, the companies claim. ... Andrew Phillips, Head of Biological Computation at Microsoft, said: "Oxford Biomedica is at the cutting edge of cell and gene
-
Novartis buys CellforCure to bolster cell, gene therapy
It says the deal would “would bolster CAR-T cell therapy manufacturing capacity with potential to expand to other cell and gene therapies in Novartis pipeline.”. ... Steffen Lang. “If completed, this acquisition also would potentially increase
-
New centre aims to Catapult UK into cell and gene therapy lead
The UK is hoping to cement its lead as a world leader in cell and gene therapy manufacturing thanks to a new ‘Catapult’ centre opened today. ... A ‘win-win’ from these discussions is as necessary as the Catapult’s work if the UK is to maintain
More from news
Approximately 1 fully matching, plus 6 partially matching documents found.
Latest Intelligence
-
Cell and gene therapy
Complexity. Manufacturing a cell or gene therapy is difficult and costly. ... Logistics. Although transportation is not part of the manufacturing process per se, it is connected and it is definitely part of the reason cell and gene therapy production is
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Training the next generation of biotech leaders
As a result, he is at the forefront of inspiring the next generation of scientists to make breakthroughs in cell and gene therapy. ... It brings engineers and people from the life sciences sector into the department to learn about biochemical engineering
-
Life at the end of the Brexit tunnel
An Advanced Therapies Treatment Centre to develop cell and gene therapies. ... Expansion of the Cell and Gene Therapy Manufacturing Centre in Stevenage.
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Sanofi's frexalimab shows promise in relapsing forms of MS
- How an AI algorithm might save your life
- EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
- Seqera Labs and Genomics England partner to progress genomic research
- Whitepaper: Closing the gap with compelling healthcare communications
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Supporting the most vulnerable: why pharma should get behind the NHS’ healthcare equity campaign
- Healing the Healers
- The (inevitable) digital transformation of Medical Affairs
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
No results were found
PMHub
Apex.co.uk Events and Exhibition Stands
Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...
Latest intelligence
- Whitepaper: Closing the gap with compelling healthcare communications
- Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
- Healing the Healers
- Because if we do not heal the healers, who is going to heal us?...
- The (inevitable) digital transformation of Medical Affairs
- It’s not a question of ‘if,’ it’s a question of ‘when.’...
